首页|基于CRISPR/Cas9技术构建PAX3-FOXO1融合基因敲除腺泡状横纹肌肉瘤细胞模型

基于CRISPR/Cas9技术构建PAX3-FOXO1融合基因敲除腺泡状横纹肌肉瘤细胞模型

扫码查看
目的 使用 CRISPR/Cas9 技术构建稳定敲除 PAX3-FOXO1 融合基因的人腺泡状横纹肌肉瘤(ARMS)细胞系(RH30),并验证 PAX3-FOXO1 功能.方法 运用在线网站针对 PAX3、FOXO1 设计 sgRNA,选择切割效率最高的一组构建 LV-PAX3-sgRNA、LV-FOXO1-sgRNA 及 LV-Cas9 慢病毒载体;LV-Cas9 病毒感染 RH30 细胞,潮霉素筛选后,通过 RT-PCR及 qRT-PCR检测RH30-Cas9 细胞中Cas9 基因表达;LV-PAX3-sgRNA及LV-FOXO1-sgRNA慢病毒载体分别感染 RH30-Cas9 细胞,流式分选筛选荧光阳性细胞;Sanger测序、PCR 等分别验证 RH30-PAX3-KO 细胞及 RH30-FOXO1-KO细胞中 PAX3-FOXO1 表达;EDU、TUNEL、Transwell实验检测敲除 RH30-PAX3-KO细胞及RH30-FOXO1-KO细胞功能改变.结果 成功构建靶向 PAX3、FOXO1 的 CRISPR/Cas9 慢病毒载体;PCR 验证稳定表达 Cas9 的 RH30 细胞系(RH30-Cas9)构建成功;PCR、Western Blot验证靶向 PAX3 或 FOXO1 均成功敲除 RH30中PAX3-FOXO1 融合基因;靶向PAX3 或FOXO1 抑制RH30 细胞增殖、侵袭、迁移,促进凋亡.结论 使用CRISPR/Cas9 成功构建敲除 PAX3-FOXO1 的 RH30 细胞系;敲除 PAX3-FOXO1 抑制了 RH30 细胞增殖、迁移等恶性生物学行为.
Construction of the PAX3-FOXO1 fusion gene knockout cell model of alveolar rhabdomyosarcoma based on CRISPR/Cas9 technology
Objective Construct a stable human alveolar rhabdomyosarcoma(ARMS)cell line(RH30)knocking out PAX3-FOXO1 fusion gene using CRISPR/Cas9 technology,and verify the function of PAX3-FOXO1.Methods Using online websites to design sgRNAs for PAX3 and FOXO1,the group with highest cutting efficiency were selected to construct LV-PAX3-sgRNA,LV-FOXO1-sgRNA,and LV-Cas9 lentiviral vectors;LV-Cas9 virus was infected into RH30,and after screened with hygromycin,the expression of Cas9 in RH30-Cas9 cells were detected by RT-PCR and qRT-PCR;Infecteded RH30-Cas9 cells with LV-PAX3-sgRNA and LV-FOXO1-sgRNA lentiviral vectors,and screened fluorescent positive cells through flow cytometry;Sanger sequencing and PCR were used to verify the expression of PAX3-FOXO1 in cell lines RH30-PAX3-KO and RH30-FOXO1-KO;EDU,TUNEL,and Transwell experiments were conducted to detect functional changes in cell lines RH30-PAX3-KO and RH30-FOXO1-KO.Results Successfully constructed CRISPR/Cas9 lentiviral vectors targeting PAX3 and FOXO1;The construction of RH30 cell line(RH30 Cas9)with stable expression of Cas9 was successfully verified by PCR;PCR and Western Blot were used to verify the successful knockout of the PAX3-FOXO1 fusion gene in RH30 targeting PAX3 or FOXO1;Targeted PAX3 or FOXO1 inhibits the proliferation,invasion,and migration of RH30 cells,promoted apoptosis.Conclusion Successful construction of RH30 cell line knocking out PAX3-FOXO1 using CRISPR/Cas9;Knockout of PAX3-FOXO1 inhibited malignant biological behaviors such as proliferation and migration of RH30 cells.

rhabdomyosarcomaPAX3-FOXO1CRISPR/Cas9genome editing

张乾儒、田娇、孟莲、史奇、李亚、夏慧欣、李锋

展开 >

石河子大学医学院病理系,新疆 石河子 832000

石河子大学第一附属医院病理科,新疆 石河子 832000

首都医科大学附属北京朝阳医院医学研究中心,北京 100020

横纹肌肉瘤 PAX3-FOXO1 CRISPR/Cas9 基因编辑

国家自然科学基金项目国家自然科学基金项目

8217305782060487

2024

石河子大学学报(自然科学版)
石河子大学

石河子大学学报(自然科学版)

CSTPCD北大核心
影响因子:0.662
ISSN:1007-7383
年,卷(期):2024.42(5)